Latest Company Announcements News

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

Unico Silver Limited reports compelling high-grade gold-silver assay results from its Joaquin Project, confirming new shallow oxide mineralisation at Breccia Puntudo and extending mineralisation at La Negra SE beyond current resource boundaries.

Patrys has initiated manufacturing and regulatory steps for RLS-2201, its injectable Quetiapine formulation targeting delirium, aiming for Phase 0 trials in the second half of 2026.

Argosy Minerals reports a 96% lithium recovery from test works at its Rincon Lithium Project and progresses critical energy infrastructure, moving closer to a final investment decision.

Stakk Limited defies the tech sector slowdown by securing nine new institutional clients in February, adding $1.67 million in annualised recurring revenue and reinforcing its AI-driven platform’s market traction.

BMG Resources has kicked off a significant 10,000-metre drilling campaign at its Abercromby Gold Project in Western Australia, aiming to grow and upgrade its existing 518,000-ounce gold resource. This move supports an upcoming scoping study and advances the project towards near-term production.

Orezone Gold Corporation reported a robust 33% increase in revenue for FY2025, underpinned by higher gold prices and the start of hard rock production at Bomboré. The company also announced a strategic acquisition of the Casa Berardi gold mine in Canada.

Murray Cod Australia Ltd reported a 40% revenue increase to $6.69 million for H1 2026 but swung to a $4.06 million net loss, reflecting significant investments and operational expansion.

Racura Oncology reported a $4.1 million loss for H1 FY26, reflecting heavy investment in clinical trials and intellectual property. The company also boosted cash reserves through capital raises and rebranded from Race Oncology.

Joyce Corporation Ltd posted robust half-year results for FY26, with revenue climbing 11.2% and net profit after tax soaring 36.1%. The company announced a fully franked interim dividend of 13 cents per share, reflecting confidence in its growth trajectory.

Bapcor Limited reported a statutory loss of $104.8 million for the first half of FY26, alongside an underlying profit in line with guidance. The company announced a $200 million equity raising to strengthen its balance sheet and fund a strategic turnaround.

Qoria Limited reported a 25% revenue increase to nearly $69 million for H1 FY2026 but also a widening net loss of $24.5 million. The company announced a transformative merger with US-based Aura to create a global digital safety leader.